CVE-2020-27276
Estado: ModificadaMedia (5.7)—
SOOIL Developments Co Ltd DiabecareRS,AnyDana-i & AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i & AnyDana-A mobile apps doesn't use adequate measures to authenticate the communicating entities before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the authentication sequence via Bluetooth Low Energy.
CVSS
- Versión: 3.1
- Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
- Puntuación base: 5.7
Probabilidad de explotación (EPSS)
- Probabilidad de explotación en los próximos 30 días: 0.50%
- Percentil entre todas las CVEs puntuadas: 41
- Fecha de la puntuación: 6/10/2026
EPSS (Exploit Prediction Scoring System, de FIRST) estima la probabilidad de que una vulnerabilidad sea explotada en 30 días. Complementa a CVSS (impacto) y a CISA KEV (explotación confirmada).
Tecnologías afectadas (3)
CWE
- CWE-290
- CWE-290
Referencias
JSON original (NVD)
Mostrar
{
"id": "CVE-2020-27276",
"cveTags": [],
"metrics": {
"cvssMetricV2": [
{
"type": "Primary",
"source": "nvd@nist.gov",
"cvssData": {
"version": "2.0",
"baseScore": 2.9,
"accessVector": "ADJACENT_NETWORK",
"vectorString": "AV:A/AC:M/Au:N/C:P/I:N/A:N",
"authentication": "NONE",
"integrityImpact": "NONE",
"accessComplexity": "MEDIUM",
"availabilityImpact": "NONE",
"confidentialityImpact": "PARTIAL"
},
"acInsufInfo": false,
"impactScore": 2.9,
"baseSeverity": "LOW",
"obtainAllPrivilege": false,
"exploitabilityScore": 5.5,
"obtainUserPrivilege": false,
"obtainOtherPrivilege": false,
"userInteractionRequired": true
}
],
"cvssMetricV31": [
{
"type": "Primary",
"source": "nvd@nist.gov",
"cvssData": {
"scope": "UNCHANGED",
"version": "3.1",
"baseScore": 5.7,
"attackVector": "ADJACENT_NETWORK",
"baseSeverity": "MEDIUM",
"vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N",
"integrityImpact": "NONE",
"userInteraction": "REQUIRED",
"attackComplexity": "LOW",
"availabilityImpact": "NONE",
"privilegesRequired": "NONE",
"confidentialityImpact": "HIGH"
},
"impactScore": 3.6,
"exploitabilityScore": 2.1
}
]
},
"affected": [
{
"source": "ics-cert@hq.dhs.gov",
"affectedData": [
{
"vendor": "n/a",
"product": "SOOIL Developments CoLtd DiabecareRS,AnyDana-i,AnyDana-A",
"versions": [
{
"status": "affected",
"version": "Dana DiabecareRS, AnyDana-i, AnyDana-A All versions prior to 3.0"
}
]
}
]
}
],
"published": "2021-01-19T17:15:12.677",
"references": [
{
"url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01",
"tags": [
"Third Party Advisory",
"US Government Resource"
],
"source": "ics-cert@hq.dhs.gov"
},
{
"url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01",
"tags": [
"Third Party Advisory",
"US Government Resource"
],
"source": "af854a3a-2127-422b-91ae-364da2661108"
}
],
"vulnStatus": "Modified",
"weaknesses": [
{
"type": "Secondary",
"source": "ics-cert@hq.dhs.gov",
"description": [
{
"lang": "en",
"value": "CWE-290"
}
]
},
{
"type": "Primary",
"source": "nvd@nist.gov",
"description": [
{
"lang": "en",
"value": "CWE-290"
}
]
}
],
"descriptions": [
{
"lang": "en",
"value": "SOOIL Developments Co Ltd DiabecareRS,AnyDana-i & AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i & AnyDana-A mobile apps doesn't use adequate measures to authenticate the communicating entities before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the authentication sequence via Bluetooth Low Energy."
},
{
"lang": "es",
"value": "SOOIL Developments Co Ltd DiabecareRS, AnyDana-i & AnyDana-A, el protocolo de comunicación de la bomba de insulina y sus aplicaciones móviles AnyDana-i, AnyDana-A no utiliza las medidas adecuadas para autenticar a las entidades comunicantes antes de intercambiar claves, lo que permite no autenticar , los atacantes físicamente próximos para rastrear la secuencia de autenticación por medio de Bluetooth Low Energy"
}
],
"lastModified": "2026-06-17T03:09:05.897",
"configurations": [
{
"nodes": [
{
"negate": false,
"cpeMatch": [
{
"criteria": "cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*",
"vulnerable": true,
"matchCriteriaId": "808DBA89-C2C2-4C03-814D-DB0B4DFF8B22",
"versionEndExcluding": "3.0"
}
],
"operator": "OR"
},
{
"negate": false,
"cpeMatch": [
{
"criteria": "cpe:2.3:h:sooil:anydana-a:-:*:*:*:*:*:*:*",
"vulnerable": false,
"matchCriteriaId": "2624582E-762F-4CDB-B974-1BC971F1544D"
}
],
"operator": "OR"
}
],
"operator": "AND"
},
{
"nodes": [
{
"negate": false,
"cpeMatch": [
{
"criteria": "cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*",
"vulnerable": true,
"matchCriteriaId": "98E25B7D-C1ED-4144-8411-171C7B6426E4",
"versionEndExcluding": "3.0"
}
],
"operator": "OR"
},
{
"negate": false,
"cpeMatch": [
{
"criteria": "cpe:2.3:h:sooil:anydana-i:-:*:*:*:*:*:*:*",
"vulnerable": false,
"matchCriteriaId": "E25CB863-07D9-4E90-8022-6C2B4C52EDFC"
}
],
"operator": "OR"
}
],
"operator": "AND"
},
{
"nodes": [
{
"negate": false,
"cpeMatch": [
{
"criteria": "cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*",
"vulnerable": true,
"matchCriteriaId": "C5C154F1-7F29-4EC0-9971-76A02C6DA8BC",
"versionEndExcluding": "3.0"
}
],
"operator": "OR"
},
{
"negate": false,
"cpeMatch": [
{
"criteria": "cpe:2.3:h:sooil:diabecare_rs:-:*:*:*:*:*:*:*",
"vulnerable": false,
"matchCriteriaId": "8628A530-AF34-453E-968A-40DD5B8EE456"
}
],
"operator": "OR"
}
],
"operator": "AND"
}
],
"sourceIdentifier": "ics-cert@hq.dhs.gov"
}